Gastrointestinal Cancer | Specialty

The OncLive Gastrointestinal Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of gastrointestinal (GI) cancers, including hepatocellular carcinoma, gastric cancer, pancreatic cancer, colorectal cancer, cholangiocarcinoma, esophageal cancer, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in GI cancers.

Dr. Van Cutsem on Regorafenib for Patients With Colorectal Cancer

July 25th 2016

Eric Van Cutsem, MD, PhD, of University Hospitals Gasthuisberg/Leuven, Leuven, Belgium, discusses regorafenib (Stivarga) as a treatment for patients with colorectal cancer.

CHMP Adopts Positive Opinion for Liposomal Irinotecan in Pancreatic Cancer

July 25th 2016

The Committee for Medicinal Products for Human Use has recommended the approval of pegylated liposomal irinotecan (Onivyde) in combination with fluorouracil and leucovorin for patients with metastatic pancreatic adenocarcinoma following progression on a gemcitabine-based therapy.

Dr. Venook on Evolving Treatment Strategies in CRC

July 22nd 2016

Alan P. Venook, MD, The Madden Family Distinguished Professor of Medical Oncology and Translational Research at the University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, discusses how treatment strategies have evolved for patients with colorectal cancer.

Dr. Udit Verma on Managing Regorafenib Side Effects in CRC

July 22nd 2016

Dr. Bekaii-Saab on Dosing Strategies With Regorafenib in CRC

July 22nd 2016

Tanios Bekaii-Saab, MD, professor of Medicine, Mayo Clinic, discusses dosing strategies with regorafenib (Stivarga) in patients with colorectal cancer (CRC).

Pancreatic Cancer: Where to Next?

July 20th 2016

The Future of Pancreatic Cancer

July 20th 2016

Immunotherapy in Pancreatic Cancer

July 20th 2016

Novel Agents in Pancreatic Cancer

July 20th 2016

PARP Inhibitors in Pancreatic Cancer

July 20th 2016

Third-Line Therapy for Pancreatic Cancer

July 20th 2016

Pancreatic Cancer: Updated NCCN Guidelines

July 20th 2016

The NAPOLI-1 Trial in Pancreatic Cancer

July 20th 2016

Pancreatic Cancer Therapeutic Sequencing

July 20th 2016

Therapy for Locally Advanced Pancreatic Cancer

July 20th 2016

Adjuvant Therapy in Locally Advanced Pancreatic Cancer

July 20th 2016

Practical Considerations in Chemotherapy Regimens for Pancreatic Cancer

July 20th 2016

Pancreatic Cancer Upfront Therapy

July 20th 2016

Continued Challenges in Pancreatic Cancer Research

July 20th 2016

Dr. Pietrantonio on Nomogram to Predict Survival Rates in CRC

July 20th 2016

Filippo Pietrantonio, MD, Department of Medical Oncology, Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan Fondazione IRCCS Istituto Nazionale dei Tumori, discusses findings of a clinical trial examining a nomogram used to predict 12-week survival rates for patients with colorectal cancer (CRC).